Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Azarga

AZARGA 10 mg/ml + 5 mg/ml eye drops, suspension · Abschnitt 4.8 · PDF-Seite 8–9

HOS-120643 · Präparat HOS-095177

8  Gastrointestinal disorders Not known: vomiting2,3, abdominal pain upper1, abdominal pain2, diarrhoea1, dry mouth1, nausea1, oesophagitis3, dyspepsia2,3, abdominal discomfort3, stomach discomfort3, frequent bowel movements3, gastrointestinal disorder3, oral hypoaesthesia3, oral paraesthesia3, flatulence3 Hepatobiliary disorders Not known: abnormal liver function test3 Skin and subcutaneous Not known: Stevens-Johnson syndrome (SJS)/toxic epidermal tissue disorders necrolysis (TEN) (see section 4.4), urticaria3, maculo-papular rash3, generalised pruritus3, skin tightness3, dermatitis3, alopecia1, psoriasiform rash or exacerbation of psoriasis2, rash1, erythema1 Musculoskeletal and Not known: myalgia1, muscle spasms3, arthralgia3, back pain3, pain connective tissue disorders in extremity3 Renal and urinary disorders Uncommon: blood urine present1 Not known: renal pain3, pollakiuria3 Reproductive system and Not known: erectile dysfunction3, sexual dysfunction2, decreased breast disorders libido2 General disorders and Uncommon: malaise1,3 administration site Not known: chest pain1, pain3, fatigue1, asthenia2,3, chest conditions discomfort3, feeling jittery3, irritability3, peripheral oedema3, medication residue3 Investigations Uncommon: blood potassium increase1, blood lactate dehydrogenase increased1 1 adverse reactions observed for Azarga 2 additional adverse reactions observed with timolol monotherapy 3 additional adverse reactions observed with brinzolamide monotherapy

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.